AMNEAL PHARMACEUTICALS, INC. Foreign Currency Transaction Gain (Loss), before Tax
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$1.95 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$1.95M, a 123.62% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$7.80M, a 283.66% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$1.44M.
- AMNEAL PHARMACEUTICALS, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$3.43M, a 250.88% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $7.63M.
- AMNEAL PHARMACEUTICALS, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$6.85M, a 509.69% decline from fiscal 2023.
- AMNEAL PHARMACEUTICALS, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was $1.67M.
- AMNEAL PHARMACEUTICALS, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$12.36M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.95M 10-Q · filed 2026-08-06 | -$9.75M 10-Q · filed 2026-08-06 | -$11.19M derived: sum of 3 quarters · filed 2026-08-06 | -$14.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$7.80M 10-Q · filed 2026-05-07 | -$9.24M derived: sum of 2 quarters · filed 2026-05-07 | -$12.67M derived: sum of 3 quarters · filed 2026-05-07 | -$4.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$4.87M derived: sum of 2 quarters · filed 2026-02-27 | $3.39M derived: sum of 3 quarters · filed 2026-08-06 | $7.63M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$3.43M 10-Q · filed 2025-11-06 | $4.83M derived: sum of 2 quarters · filed 2026-08-06 | $9.07M 10-Q · filed 2025-11-06 | $1.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $8.26M 10-Q · filed 2026-08-06 | $12.50M 10-Q · filed 2026-08-06 | $4.84M derived: sum of 3 quarters · filed 2026-08-06 | $7.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $4.25M 10-Q · filed 2026-05-07 | -$3.41M derived: sum of 2 quarters · filed 2026-05-07 | -$1.14M derived: sum of 3 quarters · filed 2026-05-07 | -$1.40M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$5.39M derived: sum of 2 quarters · filed 2026-02-27 | -$5.65M derived: sum of 3 quarters · filed 2026-02-27 | -$6.85M 10-K · filed 2026-02-27 |
| 2024-09-30 | $2.27M 10-Q · filed 2025-11-06 | $2.01M derived: sum of 2 quarters · filed 2025-11-06 | $815.00K 10-Q · filed 2025-11-06 | $3.10M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$262.00K 10-Q · filed 2025-08-07 | -$1.46M 10-Q · filed 2025-08-07 | $829.00K derived: sum of 3 quarters · filed 2026-02-27 | -$2.11M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$1.20M 10-Q · filed 2025-05-07 | $1.09M derived: sum of 2 quarters · filed 2026-02-27 | -$1.85M derived: sum of 3 quarters · filed 2026-02-27 | -$1.43M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$651.00K derived: sum of 2 quarters · filed 2026-02-27 | -$230.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.67M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$2.94M 10-Q · filed 2024-11-12 | -$2.52M derived: sum of 2 quarters · filed 2024-11-12 | -$617.00K 10-Q · filed 2024-11-12 | -$48.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $421.00K 10-Q · filed 2024-08-09 | $2.32M 10-Q · filed 2024-08-09 | $2.89M derived: sum of 3 quarters · filed 2025-02-28 | -$2.60M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $1.90M 10-Q · filed 2024-05-08 | $2.47M derived: sum of 2 quarters · filed 2025-02-28 | -$3.02M derived: sum of 3 quarters · filed 2025-02-28 | -$8.45M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $569.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$4.92M derived: sum of 2 quarters · filed 2025-02-28 | -$10.35M derived: sum of 3 quarters · filed 2025-02-28 | -$12.36M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$5.49M 10-Q · filed 2023-11-09 | -$10.92M derived: sum of 2 quarters · filed 2023-11-09 | -$12.93M 10-Q · filed 2023-11-09 | -$13.10M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | -$5.43M 10-Q · filed 2023-08-08 | -$7.44M 10-Q · filed 2023-08-08 | -$7.61M derived: sum of 3 quarters · filed 2024-03-14 | -$7.64M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | -$2.01M 10-Q · filed 2023-05-09 | -$2.18M derived: sum of 2 quarters · filed 2024-03-14 | -$2.21M derived: sum of 3 quarters · filed 2024-03-14 | -$4.46M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | -$170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$199.00K derived: sum of 2 quarters · filed 2024-03-14 | -$2.44M derived: sum of 3 quarters · filed 2024-03-14 | -$355.00K 10-K · filed 2024-03-14 |
| 2021-09-30 | -$29.00K 10-Q · filed 2022-11-07 | -$2.27M derived: sum of 2 quarters · filed 2022-11-07 | -$185.00K 10-Q · filed 2022-11-07 | $8.21M derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-06-30 | -$2.24M 10-Q · filed 2022-08-08 | -$156.00K 10-Q · filed 2022-08-08 | $8.24M derived: sum of 3 quarters · filed 2023-03-03 | $17.91M derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-03-31 | $2.09M 10-Q · filed 2022-05-06 | $10.48M derived: sum of 2 quarters · filed 2023-03-03 | $20.15M derived: sum of 3 quarters · filed 2023-03-03 | $23.62M derived: sum of 4 quarters · filed 2023-03-03 |
| 2020-12-31 | $8.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $18.07M derived: sum of 2 quarters · filed 2023-03-03 | $21.53M derived: sum of 3 quarters · filed 2023-03-03 | $16.35M 10-K · filed 2023-03-03 |
| 2020-09-30 | $9.67M 10-Q · filed 2021-11-08 | $13.14M derived: sum of 2 quarters · filed 2021-11-08 | $7.96M 10-Q · filed 2021-11-08 | $12.68M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $3.47M 10-Q · filed 2021-08-09 | -$1.72M 10-Q · filed 2021-08-09 | $3.01M derived: sum of 3 quarters · filed 2022-03-01 | -$9.52M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$5.18M 10-Q · filed 2021-05-07 | -$459.00K derived: sum of 2 quarters · filed 2022-03-01 | -$12.99M derived: sum of 3 quarters · filed 2022-03-01 | -$4.68M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$7.81M derived: sum of 2 quarters · filed 2022-03-01 | $502.00K derived: sum of 3 quarters · filed 2022-03-01 | -$4.96M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$12.53M 10-Q · filed 2020-11-06 | -$4.22M derived: sum of 2 quarters · filed 2020-11-06 | -$9.68M 10-Q · filed 2020-11-06 | -$6.87M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $8.31M 10-Q · filed 2020-08-06 | $2.85M 10-Q · filed 2020-08-06 | $5.66M derived: sum of 3 quarters · filed 2021-03-01 | $527.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$5.46M 10-Q · filed 2020-05-11 | -$2.65M derived: sum of 2 quarters · filed 2021-03-01 | -$7.78M derived: sum of 3 quarters · filed 2021-03-01 | -$33.73M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$2.32M derived: sum of 2 quarters · filed 2021-03-01 | -$28.27M derived: sum of 3 quarters · filed 2021-03-01 | -$19.70M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$5.14M 10-Q · filed 2019-11-07 | -$31.08M derived: sum of 2 quarters · filed 2019-11-07 | -$22.52M 10-Q · filed 2019-11-07 | -$19.18M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$25.95M 10-Q · filed 2019-08-05 | -$17.38M 10-Q · filed 2019-08-05 | -$14.04M derived: sum of 3 quarters · filed 2020-03-02 | -$18.22M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $8.56M 10-Q · filed 2019-05-09 | $11.91M derived: sum of 2 quarters · filed 2020-03-02 | $7.73M derived: sum of 3 quarters · filed 2020-03-02 | $23.06M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$837.00K derived: sum of 2 quarters · filed 2020-03-02 | $14.49M derived: sum of 3 quarters · filed 2020-03-02 | $29.09M 10-K · filed 2020-03-02 |
| 2017-09-30 | -$4.18M 10-Q · filed 2018-11-07 | $11.15M derived: sum of 2 quarters · filed 2018-11-07 | $25.75M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $15.33M 10-Q · filed 2018-08-09 | $29.93M 10-Q · filed 2018-08-09 | ||
| 2016-12-31 | -$14.11M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |